Blue Star Capital plc (AIM:BLU)
12.25
-0.25 (-2.00%)
Nov 21, 2025, 4:19 PM GMT+1
Blue Star Capital Revenue
Blue Star Capital had revenue of -1.01K GBP in the half year ending March 31, 2025, a decrease of -99.88%. This brings the company's revenue in the last twelve months to -4.25M, down -17.60% year-over-year. In the fiscal year ending September 30, 2024, Blue Star Capital had annual revenue of -4.33M, down -26.42%.
Revenue (ttm)
-4.25M
Revenue Growth
-17.60%
P/S Ratio
-1.37
Revenue / Employee
-2.12M
Employees
2
Market Cap
5.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | -4.33M | 1.56M | -26.42% |
| Sep 30, 2023 | -5.89M | -5.10M | 650.59% |
| Sep 30, 2022 | -784.06K | -3.24M | -131.88% |
| Sep 30, 2021 | 2.46M | 402.71K | 19.58% |
| Sep 30, 2020 | 2.06M | 2.46M | -614.50% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HSBC Holdings | 43.13B |
| Barclays | 26.02B |
| Aviva | 24.26B |
| Lloyds Banking Group | 17.93B |
| NatWest Group | 15.54B |
| Standard Chartered | 15.00B |
| Legal & General Group | 12.45B |
| Prudential | 9.74B |
Blue Star Capital News
- 5 months ago - AIM Market Roundup: Tungsten West, Blue Star Capital, Ariana Resources - The Armchair Trader
- 5 months ago - AIM Market Roundup: Autins, Haydale Graphene, Gear4music - The Armchair Trader
- 6 months ago - AIM Market Roundup: Sundae Bar, GCM Resources, Mirriad Ads - The Armchair Trader
- 6 months ago - AIM Market Roundup: Celadon Pharma, Blue Star Capital, Synergia - The Armchair Trader
- 6 months ago - AIM Market Roundup: Blue Star Capital, Pri0r1ty Intelligence, Smarttech 247 - The Armchair Trader
- 9 months ago - AIM Market Roundup: Inspiration Healthcare up 84% - The Armchair Trader
- 10 months ago - AIM Market Roundup: Blue Star Capital, Enteq, Fiinu - The Armchair Trader
- 11 months ago - AIM Market Roundup: Trellus, Falcon Oil, MyHealthChecked - The Armchair Trader